AtriCure, Inc. cotiza a 57.28 USD y tiene una capitalización bursátil de $2.9B. En los últimos 12 meses ha facturado $570M con un margen de flujo de caja libre del 9.0%. Cotiza a 54.9 veces su flujo de caja libre (P/FCF) y a un PER de 276.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Syne…
| Periodo | 2026-10 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.18 | — | $0.06 |
| Estimado | $0.01 | $0.02 | $-0.06 | $-0.04 |
| Sorpresa | — | +800.0% | — | +250.0% |
| Métrica | ATRC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 75.0% | 57.0% | +17.9% |
| Operating Margin | -1.8% | -38.6% | +36.8% |
| Net Margin | -2.1% | -33.6% | +31.4% |
| FCF Margin | 9.0% | -13.9% | +22.9% |
| ROE | -2.3% | -40.4% | +38.1% |
| ROA | -1.8% | -32.0% | +30.3% |
| Current Ratio | 3.96 | 2.84 | +1.12 |
| Debt / Equity | 0.13 | 0.28 | -0.15 |